Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Biol. Chem., Vol. 281, Issue 39, 99931, September 29, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A New Way to Degrade Amyloid Protein{diamondsuit}

In Alzheimer disease, amyloid beta-protein polymerizes into insoluble fibrils in the brain. Although the extracellular accumulation of these plaques has been the focus of most molecular studies associated with Alzheimer disease, lately, increasing attention has focused on intracellular events, including the role of the mitochondria in the disease.Go


Figure 1
Model of hPreP with amyloid beta-protein bound to the active site.

In this Paper of the Week, Annelie Falkevall and colleagues report that a novel mitochondrial metalloendopeptidase named presequence protease, or PreP, degrades amyloid beta-protein. They show that the human PreP (hPreP) is localized to the mitochondrial matrix in mammals where it degrades amyloid beta-protein. The researchers produced recombinant hPreP and characterized its proteolytic activity both in situ and in vitro. Anti-hPreP antibodies caused complete inhibition of proteolytic activity against amyloid beta-protein indicating that hPreP is responsible for degrading amyloid beta-protein when it is present in the mitochondria. Finally, the researchers investigated the degradation pattern of the amyloid beta-protein using mass spectrometric analysis and found that several unique cleavage sites were used by hPreP. These results indicate that mitochondrial degradation of amyloid beta-protein by hPreP may be important in the pathology of Alzheimer disease.

FOOTNOTES

{diamondsuit} See referenced article, J. Biol. Chem. 2006, 281, 29096-29104 Back



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement